Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Jan 5;23:12. doi: 10.1186/s12885-023-10504-2

Correction: Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients

Zhongyuan Cui 1,#, Ling Du 2,#, Jielong Wang 1,3,#, Zhongzhuan Li 2, Jiehong Xu 2, Shiyu Ou 2, Dongliang Li 1,3, Shasha Li 1,3, Hanfang Hu 2, Gang Chen 2,, Zhixian Wu 1,3,
PMCID: PMC9814441  PMID: 36604665

Correction: BMC Cancer 22, 1354 (2022)

https://doi.org/10.1186/s12885-022-10450-5

Following publication of the original article [1], the authors reported an error in the affiliation of Zhixian Wu. Zhixian Wu is affiliated to institution 1 and 3. The affiliations in this correction article have been updated and the original article [1] has been corrected.

Footnotes

Zhongyuan Cui, Ling Du and Jielong Wang contributed equally to this work.

Contributor Information

Gang Chen, Email: 13667728003@163.com.

Zhixian Wu, Email: zxwu@xmu.edu.cn.

Reference

  • 1.Cui Z, Du L, Wang J, et al. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. BMC Cancer. 2022;22:1354. doi: 10.1186/s12885-022-10450-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES